Skip to content
10-K

Annual Report

KINDRED BIOSCIENCES, INC.

0001561743-21-000024

← back to feed
Filed
Mar 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 28, 2021 41.45M sh
Capex FY 2020 · Dec 31, 2020 $3.64M
Capex FY 2020 · Dec 31, 2019 $8.43M
Capex FY 2020 · Dec 31, 2018 $13.92M
Operating Cash Flow FY 2020 · Dec 31, 2020 −$9.86M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$56.34M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$45.04M
Long Term Debt FY 2020 · Dec 31, 2020 $20.72M
Cash And Equivalents FY 2020 · Dec 31, 2020 $11.62M
Cash And Equivalents FY 2020 · Dec 31, 2019 $15.99M
Stockholders Equity FY 2020 · Dec 31, 2020 $67.48M
Stockholders Equity FY 2020 · Dec 31, 2019 $81.92M
Stockholders Equity FY 2020 · Dec 31, 2018 $91.21M
Stockholders Equity FY 2020 · Dec 31, 2017 $84.68M
Current Liabilities FY 2020 · Dec 31, 2020 $6.9M
Current Liabilities FY 2020 · Dec 31, 2019 $10.22M
Total Liabilities FY 2020 · Dec 31, 2020 $28.33M
Total Liabilities FY 2020 · Dec 31, 2019 $32.1M
Current Assets FY 2020 · Dec 31, 2020 $62.62M
Current Assets FY 2020 · Dec 31, 2019 $79.35M
Total Assets FY 2020 · Dec 31, 2020 $95.81M
Total Assets FY 2020 · Dec 31, 2019 $114.02M
Rd Expense FY 2020 · Dec 31, 2020 $31.28M
Rd Expense FY 2020 · Dec 31, 2019 $28.31M
Rd Expense FY 2020 · Dec 31, 2018 $26.4M
Net Income FY 2020 · Dec 31, 2020 −$21.8M
Net Income FY 2020 · Dec 31, 2019 −$61.39M
Net Income FY 2020 · Dec 31, 2018 −$49.69M
Operating Income FY 2020 · Dec 31, 2020 −$19.97M
Operating Income FY 2020 · Dec 31, 2019 −$62.57M
Operating Income FY 2020 · Dec 31, 2018 −$51.26M
Gross Profit FY 2020 · Dec 31, 2020 $37.54M
Gross Profit FY 2020 · Dec 31, 2019 $3.67M
Gross Profit FY 2020 · Dec 31, 2018 $1.64M
Cost Of Revenue FY 2020 · Dec 31, 2020 $4.63M
Cost Of Revenue FY 2020 · Dec 31, 2019 $587K
Cost Of Revenue FY 2020 · Dec 31, 2018 $324K
Revenue FY 2020 · Dec 31, 2020 $42.16M
Revenue FY 2020 · Dec 31, 2019 $4.26M
Revenue FY 2020 · Dec 31, 2018 $1.97M